다발골수종 CAR-T 치료제 카빅티 미국 이어 유럽 허가 medicaltimes.com - 25 Apr 2024 다발골수종 CAR-T 치료제 카빅티 미국 이어 유럽 허가 ... More
Multiple Myeloma: What's a Therapy 'Line'? HealthTree - 29 Apr 2024 Multiple Myeloma: What's a Therapy 'Line'? ... More
15th International Myeloma Foundation gala raises over $675K Myeloma Research News - 30 Apr 2024 15th International Myeloma Foundation gala raises over $675K ... More
The enduring neutrophil–stroma dance of multiple myeloma Nature - 10 Apr 2024 The enduring neutrophil–stroma dance of multiple myeloma ... More
Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma OncLive - 29 Apr 2024 Dr Anderson on the FDA ODAC Decision Regarding Cilta-Cel in R/R Multiple Myeloma ... More
Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma Oncology Nursing News - 27 Apr 2024 Cranial Nerve Palsy May Be Present After Cilta-Cel for Multiple Myeloma ... More
Rheological properties of blood in multiple myeloma patients | Scientific Reports Nature - 21 Feb 2024 Rheological properties of blood in multiple myeloma patients | Scientific Reports ... More
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with ... Nature - 09 Nov 2023 Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with ... ... More
The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease Nature - 19 Mar 2024 The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease ... More
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide | Blood Cancer Journal Nature - 26 Mar 2024 Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide | Blood Cancer Journal ... More
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma Nature - 08 Feb 2024 Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma ... More
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal Nature - 05 Mar 2024 Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal ... More
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier | Leukemia Nature - 09 Mar 2024 Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier | Leukemia ... More
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with ... Nature - 20 Feb 2024 Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with ... ... More
CAR T therapies in multiple myeloma: unleashing the future | Cancer Gene Therapy Nature - 04 Mar 2024 CAR T therapies in multiple myeloma: unleashing the future | Cancer Gene Therapy ... More
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA ... Nature - 06 Mar 2024 Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA ... ... More
A population-based study on incidence trends of myeloma in the United States over 2000–2020 | Scientific Reports Nature - 24 Nov 2023 A population-based study on incidence trends of myeloma in the United States over 2000–2020 | Scientific Reports ... More
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review | Blood Cancer Journal Nature - 02 Feb 2024 GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review | Blood Cancer Journal ... More
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT ... Nature - 21 Feb 2024 Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT ... ... More